The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte CHIN-WEN CHI, HENG-LIANG LIN, TSUNG-YUN LIU,
WING-YIU LUI and GAR-YANG CHAU
__________
Appeal No. 2006-0674
Application No. 10/083,565
__________
ON BRIEF
__________
Before SCHEINER, ADAMS and GREEN, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves claims directed to treatment of hepatocellular carcinoma by
intravenous administration of docetaxel. The examiner has rejected claims 7-9, 12 and
16-22 as obvious over the prior art. Claims 13-15 are also pending, but have been
withdrawn from consideration. We have jurisdiction under 35 U.S.C. § 134. We find that
the examiner has not established a prima facie case of unpatentability, and reverse the
rejection.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007